Last updated: August 11, 2014
Sponsor: Yonsei University
Overall Status: Completed
Phase
3
Condition
Hypertriglyceridemia
Treatment
N/AClinical Study ID
NCT02215694
probiotics_140801
Ages 24-68 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
nondiabetic (plasma fasting glucose, <126mg/dL; 2-hour plasma glucose, <200mg/dL)
borderline to moderate hypertriglyceridemia (plasma triglyceride, 150-500 mg/dL)
Exclusion
Exclusion Criteria:
lipid-lowering medications use
any medications or supplement use
any probiotics products use for the past 1 months
dyslipidemia
diabetes mellitus
hypertension
liver disease
renal disease
cardiovascular disease
cerebrovascular disease
pancreatitis
cancer
medication or alcohol abuse
pregnant or breast feeding
Study Design
Total Participants: 128
Study Start date:
June 01, 2012
Estimated Completion Date:
March 31, 2014
Study Description
Connect with a study center
Laboratory of Clinical Nutrigenetics/Nutrigenomics
Seoul, 120-749
Korea, Republic ofSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.